Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma: a new staging classification.

R L Krigel, L J Laubenstein, F M Muggia

    Cancer Treatment Reports
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus.

    Gynecologic oncology·2024
    Same author

    BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    Brain metastases from choriocarcinoma: two patients illustrating key management issues.

    Journal of chemotherapy (Florence, Italy)·2008
    Same author

    Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
    Same author

    Platinums: extending their therapeutic spectrum.

    Journal of chemotherapy (Florence, Italy)·2005
    Same author

    'Retarded pharmaceuticals' assuming a clinical role.

    Onkologie·2004
    Same journal

    Rhabdomyolysis associated with high-dose cytarabine.

    Cancer treatment reports·1987
    Same journal

    Acute laryngeal edema after single-dose irradiation and doxorubicin.

    Cancer treatment reports·1987
    Same journal

    Timing may be a critical factor in drug therapy.

    Cancer treatment reports·1987
    Same journal

    Prednimustine in advanced malignant melanoma: a phase II study.

    Cancer treatment reports·1987
    Same journal

    Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    Same journal

    Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    See all related articles

    A new staging system for Kaposi's sarcoma is proposed, identifying four distinct clinical forms. This system aims to improve patient group definition for evaluating treatment efficacy in Kaposi's sarcoma.

    Area of Science:

    • Oncology
    • Epidemiology
    • Infectious Diseases

    Background:

    • Reports of a novel Kaposi's sarcoma (KS) form in young homosexual men indicate limitations in existing classification systems.
    • Previous KS classifications do not fully encompass the diverse clinical presentations observed.
    • The emergence of KS in specific demographics necessitates a revised understanding of the disease.

    Purpose of the Study:

    • To describe the clinical characteristics of Kaposi's sarcoma in a cohort of homosexual men.
    • To propose a new, comprehensive staging system for Kaposi's sarcoma based on clinical presentation.
    • To establish a framework for evaluating treatment regimens in uniformly defined patient groups.

    Main Methods:

    • Clinical data from 49 homosexual men diagnosed with Kaposi's sarcoma were analyzed.

    Related Experiment Videos

  • Four distinct clinical forms of Kaposi's sarcoma were identified and described.
  • A subtyping system was developed based on the presence or absence of systemic symptoms like fever or weight loss.

    • Main Results:

    • Four clinically distinct stages of Kaposi's sarcoma were proposed: Stage I (indolent, typical), Stage II (locally invasive, Africa), Stage III (disseminated mucocutaneous, lymph node involvement), and Stage IV (disseminated, visceral involvement).
    • Stages III and IV were observed in African children and North American homosexual men.
    • Subtyping included assessment of systemic signs such as fever and weight loss.

    Conclusions:

    • The proposed four-stage system categorizes Kaposi's sarcoma based on distinct clinical features and geographic/demographic associations.
    • This staging system requires further validation through longitudinal studies to correlate with survival data.
    • The proposed staging aims to facilitate standardized patient group definition for treatment efficacy assessment.